Immunome to Present at Upcoming Investor Conferences

BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class cancer therapies, today announced that members of the company’s management team will present at the following investor conferences: 9th Annual Evercore Healthcare Conference Presentation Date/Time: December 1, 2026, at 9:10 a.m. ET Piper Sandler 38th Annual Healthcare Conference Presentation Date/Time: December 2, 2026, at 10:30 a.m.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.